KIA
REGN icon

KCM Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

KCM Investment Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-914
Closed -$315K – 538
2018
Q1 		$315K Sell
914
-22
-2% -$7.65K 0.02% 426
2017
Q4 		$352K Buy
936
+241
+35% +$97.6K 0.02% 411
2017
Q3 		$311K Sell
695
-432
-38% -$206K 0.02% 424
2017
Q2 		$554K Sell
1,127
-35
-3% -$15.3K 0.03% 340
2017
Q1 		$450K Hold
1,162
– – 0.03% 374
2016
Q4 		$427K Hold
1,162
– – 0.03% 381
2016
Q3 		$467K Sell
1,162
-65
-5% -$26.1K 0.03% 373
2016
Q2 		$429K Buy
1,227
+143
+13% +$55.1K 0.03% 380
2016
Q1 		$391K Sell
1,084
-215
-17% -$88.6K 0.03% 379
2015
Q4 		$705K Buy
1,299
+203
+19% +$110K 0.06% 287
2015
Q3 		$510K Sell
1,096
-188
-15% -$101K 0.04% 338
2015
Q2 		$655K Buy
1,284
+6
+0.5% +$2.93K 0.05% 308
2015
Q1 		$577K Sell
1,278
-146
-10% -$61.9K 0.05% 325
2014
Q4 		$584K Buy
1,424
+309
+28% +$122K 0.05% 316
2014
Q3 		$402K Sell
1,115
-386
-26% -$129K 0.04% 361
2014
Q2 		$424K Buy
1,501
+23
+2% +$6.82K 0.04% 347
2014
Q1 		$444K Sell
1,478
-117
-7% -$36K 0.05% 307
2013
Q4 		$439K Buy
+1,595
New +$459K 0.05% 302

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

KCM Investment Advisors's REGN Position: Q2 2018 in Review

KCM Investment Advisors sold out of Regeneron Pharmaceuticals (REGN) in Q2 2018, closing a stake of 914 shares — an estimated $315K sold.

KCM Investment Advisors first reported a position in REGN in Q4 2013 and held it in 18 quarters. The position peaked at $705K in Q4 2015. 624 funds tracked by Wall St. Rank hold REGN as of Q2 2018.

  • KCM Investment Advisors reported no remaining Regeneron Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • KCM Investment Advisors sold 914 Regeneron Pharmaceuticals shares in Q2 2018, an estimated $315K.
  • KCM Investment Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2013 and held it in 18 quarters.
  • KCM Investment Advisors's Regeneron Pharmaceuticals position peaked at $705K in Q4 2015.
  • 624 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2018.

Based on KCM Investment Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.